Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Indolent NHL subject of Cell Therapeutics' phase III trial with pixantrone

Sep. 13, 2007

Ariad and FDA agree on SPA for phase III trial of deforolimus for metastatic sarcomas

Sep. 13, 2007

FDA approves Adventrx clinical development plan for ANX-514

Sep. 12, 2007

Spectrum begins enrolling patients in second pivotal phase III trial of EOquin

Sep. 12, 2007

MHLW approves Taiho's antimetabolite TS1 capsules for biliary cancer

Sep. 10, 2007

Kosan receives SPA for TIME-1 trial of tanespimycin in multiple myeloma

Sep. 10, 2007

FDA grants fast track designation to Poniard's picoplatin for SCLC

Sep. 7, 2007

Cell Therapeutics to conduct full analysis of EXTEND trial after discussions with FDA

Sep. 7, 2007

Resin increases production of NPI-0052 during fermentation of Salinispora tropica

Sep. 7, 2007

Advanced Viral Research expects to begin phase II trial of AVR-118

Sep. 6, 2007

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...